Premium
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its lead drug candidate comprises CUE-101, a variant ... Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its lead drug candidate comprises CUE-101, a variant form of the cytokine Interleukin-2 and a T cell antigen to target and activate T cells specific to HPV-related cancers. The other products under pipeline are CUE-102, CUE-103, CUE-400, and CUE-401. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.12 | -9.75609756098 | 1.23 | 1.33 | 1.07 | 216281 | 1.21519145 | CS |
| 4 | -0.31 | -21.8309859155 | 1.42 | 1.54 | 1.07 | 178932 | 1.30350795 | CS |
| 12 | 0 | 0 | 1.11 | 1.75 | 0.92 | 293780 | 1.27562905 | CS |
| 26 | 0.445 | 66.9172932331 | 0.665 | 1.9891 | 0.45 | 537877 | 1.25648153 | CS |
| 52 | -0.95 | -46.1165048544 | 2.06 | 2.26 | 0.45 | 436288 | 1.2748357 | CS |
| 156 | -3.94 | -78.0198019802 | 5.05 | 6.29 | 0.45 | 347113 | 2.53911525 | CS |
| 260 | -20.28 | -94.8106591865 | 21.39 | 35.5 | 0.45 | 339772 | 7.3538486 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
